AROC Adds NYSE Texas Listing; Press Release Attached

Rhea-AI Filing Summary

Archrock, Inc. filed a registration statement on Form 8-A to effect a dual listing of its common stock, $0.01 par value per share, on NYSE Texas under the trading symbol AROC. The company's common stock remains listed on the New York Stock Exchange under the same symbol.

A press release announcing the dual listing is attached as Exhibit 99.1 and is incorporated by reference, and the filing lists a cover page interactive data file as Exhibit 104.

Positive

• Registered dual listing of common stock on NYSE Texas under the symbol AROC
• Press release announcing the dual listing is attached as Exhibit 99.1

Negative

• None.

Insights

Securities Analyst

TL;DR Archrock's Form 8-A registers a dual listing on NYSE Texas for its common stock (AROC), a procedural step that can broaden trading venues.

The filing documents a registration on Form 8-A to enable a secondary listing of the company's common shares on NYSE Texas while preserving its existing NYSE listing. This is primarily a market-structure action rather than an operational or financial change; the filing includes an attached press release as Exhibit 99.1 and an interactive data file listed as Exhibit 104. Investors should note this expands formal trading venues but does not, by itself, alter capital structure or reported financials.

Corporate Governance Expert

TL;DR Filing a Form 8-A for a dual listing is a governance and disclosure action that formalizes additional market access for shareholders.

The company has used Form 8-A to register its common stock for listing on NYSE Texas under the symbol AROC while maintaining its New York Stock Exchange listing. The disclosure includes a press release as Exhibit 99.1, which the company incorporated by reference. From a governance perspective, dual listings typically require coordination with exchange rules and ongoing compliance across jurisdictions; the filing itself documents the registration step but does not provide detail on exchange-specific approvals or expected timing.

false 0001389050 0001389050 2025-08-12 2025-08-12 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 12, 2025

ARCHROCK, INC.

(Exact name of registrant as specified in its charter)

Delaware		001-33666		74-3204509
(State or other jurisdiction of incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

9807 Katy Freeway, Suite 100, Houston, TX
(Address of principal executive offices) 77024
(Zip Code)

(281) 836-8000

Registrant’s telephone number, including area code

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of exchange on which registered
Common stock, $0.01 par value per share		AROC		New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 8.01. Other Events.

Archrock Inc. filed a registration statement on Form 8-A with the Securities and Exchange Commission in connection with the dual listing of its common stock, $0.01 par value per share (the “Common Stock”) with NYSE Texas, Inc. under the trading symbol “AROC.” The Common Stock is currently listed on the New York Stock Exchange under the symbol “AROC.”

A copy of the press release announcing the dual listing is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated into this Item 8.01 by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit Number		Description
99.1		Press Release of Archrock, Inc., dated August 12, 2025
104		Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	ARCHROCK, INC.
Dated: August 12, 2025	By:	/s/ Stephanie C. Hildebrandt
		Stephanie C. Hildebrandt
		Senior Vice President, General Counsel and Secretary

FAQ

What action did Archrock (AROC) take in this Form 8-K?

The company filed a registration statement on Form 8-A to enable a dual listing of its common stock on NYSE Texas under the trading symbol AROC.

Is Archrock's common stock still listed on the New York Stock Exchange?

Yes. The filing states the common stock remains listed on the New York Stock Exchange under the symbol AROC.

What exhibits were included with the filing?

The filing attaches a press release as Exhibit 99.1 and lists a cover page interactive data file as Exhibit 104.

What is the par value of Archrock's common stock as stated in the filing?

The common stock is stated as having a par value of $0.01 per share.

Does the Form 8-K describe any financial impact from the dual listing?

No. The filing discloses the registration for a dual listing and attaches a press release; it does not present financial statements or quantify financial impact.